BayMark Calls for Incentives to Serve Rural Areas, Changes in Medicare Advantage
Behavioral Health Business October 16, 2024
Companies that treat opioid use disorder could commend themselves last month when the federal government reported overdose deaths were down nearly 11% for the first eight months of 2024, marking the second-straight year of decline.
“It’s fantastic news,” Jason Kletter, president of BayMark Health Services, told Addiction Treatment Business. “It’s something to celebrate.”
But the Centers for Disease Control and Prevention (CDC) numbers also point to concerns.
For one, those aged 65 and older saw an increase in fatal overdoses, including a 9% climb in the last six months of 2023. An increase in elderly overdoses come as Medicare Advantage patients struggle to access medication for opioid addiction, according to a U.S. Department of Health and Human Services Office of...